Turn Therapeutics Inc.
TTRX
$5.25
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 100.40% | 1.85% | -35.61% | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 102.29% | 13.33% | -23.76% | -- | -- |
| Operating Income | -102.29% | -13.33% | 23.76% | -- | -- |
| Income Before Tax | -91.26% | -8.86% | 24.49% | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -91.26% | -8.86% | 24.49% | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -91.26% | -8.86% | 24.49% | -- | -- |
| EBIT | -102.29% | -13.33% | 23.76% | -- | -- |
| EBITDA | -104.22% | -13.26% | 24.39% | -- | -- |
| EPS Basic | -85.07% | -6.37% | 25.64% | -- | -- |
| Normalized Basic EPS | -85.98% | -6.74% | 25.37% | -- | -- |
| EPS Diluted | -85.07% | -6.37% | 25.64% | -- | -- |
| Normalized Diluted EPS | -85.98% | -6.74% | 25.37% | -- | -- |
| Average Basic Shares Outstanding | 2.92% | 1.99% | 1.33% | -- | -- |
| Average Diluted Shares Outstanding | 2.92% | 1.99% | 1.33% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |